Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Tackling Bias in Health
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
African Cancer Database Debuts
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
A Ghanaian Scientist’s Quest to Create a Genetic Map of Cancer in Africa
Sequencing the human genome enables scientists to study human biology in a granular fashion and use that information to create treatments for things like cancer. Yet, of the human genomes studied so far, only 2% have been those of Africans. Yemaachi Biotech company in Ghana is addressing that through its Africa Cancer Atlas, partnering with […]
Yemaachi Biotech, the Ghanaian Company Building the “African Cancer Atlas”
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
‘The Field of Human Ancestry is Rife with Racism’: Pioneering Project to Build Cancer Database in Africa.
When Yaw Bediako lost his father to liver cancer, it set the Ghanaian immunologist on a journey to know more about the disease. He quickly realised the burden of cancer in Africa was much greater than he had thought – accounting for about 700,000 deaths every year – and that very few scientific papers about the disease […]
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership with Roche
Roche has signed as the founding partner to initiate the consortium which will generate genomic and clinical data from up to 7,500 African cancer patients ACCRA, Ghana & WASHINGTON–(BUSINESS WIRE)–Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch The African Cancer Atlas (TACA). This initiative aims […]
Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases
Emmanuella Amoako abc, Setor Amuzu a, Emmanuel Owusu Ofori b, Harry Sefoga Akligoh a, Randy Tackie a, Barikisu Anna Ibrahim a, Emmanuel Kofi Quaye a, Patrick Kafui Akakpo bcd, Luke Adagrah Aniakwo b, Bashiro Jimah bc, Kofi Ulzen-Appiah bc, David Hutchful a, Aida Manu a, Joyce M Ngoi a, Lily Paemka a, Yakubu Alhassan ae, Ernest Amo Obeng d, Nicole Lim f, Lisa Rajah f, Michelle Pek f…Yaw Bediako a Transl Oncol; 49: 102100, 2024 Nov, https://doi.org/10.1016/j.tranon.2024.102100 Abstract Purpose: Breast cancer is a major cause of cancer-related mortality among African women. The adoption of molecular genomic technologies in the management of cancer cases is limited in Africa. To provide much-needed insights on the feasibility and utility […]
Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria
We are pleased to share a paper from our first research collaboration with West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) – University of Ghana, where we explored the link between malaria and lower COVID-19 deaths in Africa. This project is supported by Google, Bill & Melinda Gates Foundation and The Rockefeller Foundation.